Home
Live Updates
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees : vimarsana.com
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
FREMONT, CA , Jan. 03, 2024 -- via NewMediaWire – ABVC BioPharma, Inc. and its subsidiary BioLite, Inc. , a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Related Keywords
San Francisco ,
California ,
United States ,
Stanford University ,
Delaware ,
Fremont ,
Russman Jaimes ,
Uttam Patil ,
Leeds Chow ,
Company Annual Report On Form ,
Straits Research ,
Globenewswire Inc ,
Sinai Medical Center ,
Biopharma Inc ,
Exchange Commission ,
Biolite Inc ,
Nasdaq ,
Aibtl Biopharma Inc ,
University Of California ,
Btl Biopharma ,
Major Depressive Disorder ,
Attention Deficit Hyperactivity Disorder ,
Chief Executive Officer ,
Future Market Insights ,
Sinai Medical ,
For Vitargus ,
Market Approval ,
Annual Report ,
Quarterly Reports ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.